Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose vs Glipizide on Microbiome and Incretins in Type 2 Diabetes
NCT01758471Phase 4Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Dec 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acarbose in type 2 diabetes mellitus (T2DM), sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.
02
Drugs
acarbose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01758471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01758471.